Induction of cancer cell stemness by chemotherapy
Volume 11, Issue 14
Purchase or Subscribe
July 15, 2012
Pages 2691 - 2698http://dx.doi.org/10.4161/cc.21021
: cancer stem cells, carboplatin, hepatocellular carcinoma, liver cancer, tumor-initiating cells
Authors: Xingwang Hu, Laura Ghisolfi, Andrew C. Keates, Jian Zhang, Shuanglin Xiang, Dong-ki Lee and Chiang J. Li View affiliations
Recent studies indicate that cancer stem cells (CSCs) exist in most hematological and solid tumors. CSCs are characterized by their ability to self-renew and their capacity to differentiate into the multitude of cells that comprise the tumor mass. Moreover, these cells have been shown to be intrinsically resistant to conventional anticancer therapies. Despite their fundamental role in cancer pathogenesis, the cellular origin of CSCs remains highly controversial. The aim of this study was to examine whether heterogeneous cancer cells can acquire stem cell-like properties in response to chemotherapy. We demonstrate that carboplatin can induce the self-renewal (spherogenesis) and pluripotency (Sox2 and Oct3/4 expression) of hepatocellular carcinoma (HCC) cells grown under stem cell culture conditions. Moreover, we show that non-CSC cells, obtained by side population flow cytometric sorting using Hoechst 33342, can acquire stem-like properties after exposure to carboplatin. Finally, we show that knockdown of Sox2 and Oct3/4 gene expression in HCC cells can reduce carboplatin-mediated increases in sphere formation and increase cellular sensitivity to chemotherapy. Taken together, our data indicate that bulk cancer cells may be an important source of CSCs during tumor development, and that targeting Sox2 and/or Oct3/4 may be a promising approach for targeting CSCs in clinical cancer treatment.
Received: May 31, 2012; Accepted: June 5, 2012
Full Text - Ahead of Print Available - Log in!